🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase 1 first-in-human single ascending dose study will be a randomize...
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2015-08
Trial ID
NCT02531815
Treatments Being Tested
This is a randomized, placebo-controlled, multiple dose escalation study to...
Status
Completed
Location
Multiple Locations
Start Date
2015-03
Trial ID
NCT03006159
This is a single center, double-blinded, randomized, placebo controlled sin...
Status
Completed
Location
Worldwide Clinical Trials
Start Date
2022-06-06
Trial ID
NCT06769620
A safety study of KAN-101 in patients with celiac disease. The study has tw...
Status
Completed
Location
Anaheim Clinical Trials
Start Date
2020-01-21
Trial ID
NCT04248855
This is a prospective, double-blind, randomized, placebo-controlled study i...
Status
Terminated
Location
Sanford Health
Start Date
2020-05-14
Trial ID
NCT04372017
Treatments Being Tested
This is a Phase 1 study to assess the the safety, tolerability and pharmaco...
Status
Completed
Location
Research Site
Start Date
2022-04-04
Trial ID
NCT05351047
Treatments Being Tested
This is a randomized, placebo-controlled, double-blind, 3-way crossover pha...
Status
Completed
Location
Research Site
Start Date
2017-09-06
Trial ID
NCT03258515
Treatments Being Tested
The main purpose of this study is to assess how well LY3971297 is tolerated...
Status
Recruiting
Location
Henry Ford Health System
Start Date
2026-08-11
Trial ID
NCT07547540
This is a the first in human study to evaluate the safety, tolerability, PK...
Status
Completed
Location
Huashan Hospital Affiliated to Fudan University
Start Date
2020-08-27
Trial ID
NCT04511624
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability and pharmac...
Status
Completed
Location
Hammersmith Medicines Research
Start Date
2015-08-26
Trial ID
NCT02561156
Treatments Being Tested